CME/CE Quiz

Take CME Quiz Online

CME/CE QUESTIONS

Accreditation Statement

Physicians Continuing Medical Education

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through sponsorship of Professional Resources In Management Education, Inc (PRIME^®). PRIME^® is accredited by ACCME to provide continuing medical education for physicians. PRIME^® designates this educational activity for a maximum of 2.0 category 1 credits toward the AMA Physician's Recognition Award. Physicians should claim only those hours of credit that they actually spent on this activity.

Pharmacists Continuing Education

PRIME^® is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and complies with the Criteria for Quality for continuing pharmacyl education programming. The universal program number for this activity is 255-000-05-025-H01. This activity is approved for 2.0 contact hours by PRIME^®. In order to receive a Statement of Credit for this activity, pharmacists must read the program, successfully pass the posttest, and complete the program evaluation.

Nursing Continuing Education

PRIME^® designates this educational activity for 2.0 contact hours by the Florida Board of Nursing and the California Board of Registered Nursing.

Case Management Continuing Education

The Commission for Case Manager Certification has approved this educational activity for 2.0 contact hours for certified case managers through PRIME^®.

1. Because of the significant investment of resources within managed care, including asthma disease management models, case management, population health initiatives, and recently imposed pharmacy-based adherence protocols, the costs associated with asthma have substantially decreased.

• False

2. Asthma is a chronic inflammatory disorder of the airways that is characterized by recurrent episodes of all of the following except:

• Dyspnea.
• Headaches.

3. The gold standard in diagnosing asthma is spirometry.

• False

4. Managing asthma involves the following components:

• Controlling asthma triggers.
• All of the above

5. Reasons responsible for lack of adherence to clinical guidelines include all but which of the following?

• Poor compliance on the part of the patient
• Lack of health insurance for patients with asthma

6. Most patients tend to be accurate when reporting to their primary physicians on the severity of their condition but underestimate their level of control regarding the disease.

• False

7. Patients with moderate-to-severe persistent asthma who continue to have exacerbations may benefit from treatment with which of the following?

• A ventilator
• Admission to the hospital

8. Anxiety and depression have no impact on the management of patients with mild-to-moderate severe asthma.

• False

9. Managed care companies are uniquely poised to assist the provider in managing the asthma patient.

• False

10. Utilization of guidelines and evolving concepts of asthma control versus asthma severity can be important in improving the management of patients with asthma.

• False

Program Evaluation for Discussing the COSTS of Asthma: Controlling Outcomes, Symptoms, and Treatment Strategies

To receive CME/CE instantly please:

• This posttest is provided as a reference for your review; do not submit it by mail for credit.
• Follow the instructions for obtaining your certificate of completion or statement of credit.

There is no cost to participate in this activity, as it is supported through an educational grant from Genentech, Inc and Novartis Pharmaceuticals, Inc.

Original Release Date: November 1, 2005

Expiration Date: October 31, 2006

Program Evaluation

PRIME^® values your opinion and asks you to assist us in evaluating the effectiveness of this activity and to make recommendations for future educational offerings. Please complete this evaluation form by circling the most appropriate rating using the following scale.

1 = Poor, 2 = Fair, 3 = Satisfactory, 4 = Good, 5 = Excellent

The goal of this program is to provide information that professionals can use in their daily practice to improve the quality of life for the asthma patient by understanding how to decrease symptoms, decrease morbidity, and decrease the use of healthcare resources.

Rate the extent to which the program met the identified objectives:

Define guideline-based asthma control and its applicability to the management of asthma in the managed care setting.

1 2 3 4 ; 5

State the effects of current asthma treatment options on lung function, resource utilization, and symptom control, as well as the proper position of these agents in asthma treatment regimens.

1 2 3 4 ; 5

Describe reasons for suboptimal patient outcomes and discuss methods to improve such outcomes in managed care-based comprehensive asthma management programs.

1 2 3 4 ; 5

Relevance to Practice: Please choose the most appropriate answer:

• The program greatly increased my knowledge of the barriers related to effective management of patients with mild-to-moderate asthma.
• The program presented information and resources that were new.

Application to Practice: Please choose the most appropriate answer:

• The program provided evidence-based information that explained the rationale for decisions regarding the management and treatment of patients with mild-to-moderate asthma.
• The program was interesting and will be used as a reference for managing patients with mild-to-moderate asthma.

The information was presented in a fair and balanced manner. Yes ___ No___

If no, please explain:

______________________________________________________________________________________________________________________________________________________________

Recommendations for further information on this topic or other areas of interest in your professional practice:

______________________________________________________________________________________________________________________________________________________________

Intended Audience

Medical directors, pharmacists, case managers, and nurses in managed care organizations.

Learning Objectives

• Define guideline-based asthma control and its applicability to the management of asthma in the managed care setting.
• Describe reasons for suboptimal patient outcomes and discuss methods to improve such outcomes in managed care-based comprehensive asthma management programs.

Accreditation Statement

Physicians Continuing Medical Education

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through sponsorship of Professional Resources In Management Education, Inc (PRIME^®). PRIME^® is accredited by ACCME to provide continuing medical education for physicians. PRIME^® designates this educational activity for a maximum of 2.0 category 1 credits toward the AMA Physician's Recognition Award. Physicians should claim only those hours of credit that they actually spent on this activity.

Pharmacists Continuing Education

PRIME^® is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and complies with the Criteria for Quality for continuing pharmaceutical education programming. The universal program number for this activity is 255-000-05-025-H01. This activity is approved for 2.0 contact hours by PRIME^®. In order to receive a Statement of Credit for this activity, pharmacists must read the program, successfully pass the posttest, and complete the program evaluation.

Nursing Continuing Education

PRIME^® designates this educational activity for 2.0 contact hours by the Florida Board of Nursing and the California Board of Registered Nursing.

Case Management Continuing Education

The Commission for Case Manager Certification has approved this educational activity for 2.0 contact hours for certified case managers through PRIME^®.

To Receive Your CME/CE Credit

Instant CME/CE:

• Go to www.ajmc.com/asthmace. Click on CME/CEQuiz.
• Follow the simple instructions for obtaining your certificate of completion.

There is no cost for this activity.

Acknowledgment of Commercial Support

This program is supported by an unrestricted educational grant from Genentech Inc. and Novartis Pharmaceuticals Inc.

Original Release Date: November 1, 2005

Expiration Date: October 31, 2006

Download PDF: CME/CE Quiz